Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0256-2008

BioPlex 2200 System, Cat. No. 665-1460A containing APF CD SW2_v1., Syphilis IgG IFU Packet contains the...

Bio-Rad Laboratories Inc. / initiated 2007-09-25 / Terminated / root cause: labeling and UDI

Bio-Rad Labroatories Inc. began a recall of BioPlex 2200 System, Cat. No. 665-1460A containing APF CD SW2_v1., Syphilis IgG IFU Packet contains the Syphilis IgG Assay Protocol File LAPF CD on . The reason FDA records is "Mislabeling: Reporting terminology in the Syphilis IgG APF CD is not consistent with the distributed Instructions for Use. (Non-Reactive and Reactive rather than Negative and Positive)". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-0256-2008
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Bio-Rad Laboratories Inc.
Product
BioPlex 2200 System, Cat. No. 665-1460A containing APF CD SW2_v1., Syphilis IgG IFU Packet contains the Syphilis IgG Assay Protocol File LAPF CD
Product code
LIP Enzyme Linked Immunoabsorption Assay, Treponema Pallidum
Reason for recall
Mislabeling: Reporting terminology in the Syphilis IgG APF CD is not consistent with the distributed Instructions for Use. (Non-Reactive and Reactive rather than Negative and Positive)
Root cause tag
labeling and UDI
FDA root cause
Labeling Change Control
Action
The recalling firm notified consignees by phone call on 9/25/2007, followed up with a fax notification. The firm plans to monitor the consignees that do not respond by tracking on a spreadsheet and following up with another phone call. Consignees are instructed to destroy the APF CD which will be replaced at a later date.
Quantity in commerce
36
Distribution
Nationwide
Product codes and lots
Cat. No. 665-1460A containing APF CD SW2_v1.